Skip to content

Non-Invasive Quantitative Imaging of Human Local Arterial Wall Elasticity Using Supersonic Shear Imaging

Establishment of Local Arterial Stiffness Normal Values (Carotid and Femoral) on Healthy Volunteers Using Supersonic Shear Imaging

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01096264
Acronym
ULTRAFASTECHO
Enrollment
145
Registered
2010-03-31
Start date
2010-03-31
Completion date
2011-03-31
Last updated
2015-03-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy Volunteers, Vascular Ehlers Danlos Syndrome

Keywords

Arterial stiffness, Pulse wave velocity, Ultrafastecho, Supersonic shear imaging

Brief summary

Arterial stiffness is associated with increased risk of cardiovascular events and death. Most of existing technique need dedicated device for arterial stiffness evaluation and indirect calculation of intra arterial pressure. Supersonic Shear Imaging (SSI) is a novel non-invasive technique based on remote palpation of biological tissues that can image with very high temporal resolution (up to 10,000 images/s) and quantify the local viscoelastic properties of tissues. The investigators goal was to apply this SSI technique for arterial stiffness evaluation and local pulse wave velocity (PWV) calculation. As a first step, the primary goal of this study is to establish normal values of local pulse wave velocity and arterial stiffness (carotid and femoral) by SSI on hundred healthy volunteers.

Detailed description

Provide a more extensive description, if desired. Avoid duplication of information to be recorded elsewhere, such as eligibility criteria or outcome measures.

Interventions

OTHERSSI and SphygmoCor® evaluations

* SSI evaluation need Aixplorer vascular ultrasound machine (available in our department) with 8 MHz linear array probe applied on the carotid and femoral artery. * SphygmoCor® evaluation used pressure captors on carotid and femoral sites to record the intra-arterial pressure wave time delay after QRS wave. After distance calculation between the two sites, Aortic PWV can be derived.

Sponsors

National Research Agency, France
CollaboratorOTHER
SOCIETE FRANCAISE DE MEDECINE VASCULAIRE
CollaboratorUNKNOWN
French Cardiology Society
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
FACTORIAL
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 70 Years
Healthy volunteers
Yes

Inclusion criteria

for Healthy Volunteers * Healthy volunteers between 18 and 70 years old of two sexes. * Caucasian origin * No tobacco or stopped for more than 5 years * BMI between 18 and 30 kg/m2. * Blood pressure after 5 minutes of rest \< 140 and 90 mmHg. * Biological test (haematological biochemistry test in blood , urine test and toxicology tests are all normal) ECG, Blood pressure and Heart rhythm normal. * All volunteers received information on the research and signed the consent form. * Health system protection required Inclusion criteria for patient : * Age between, 18 et 70 years old for the two sexes * Presence of two major criteria of Villefranche classification (Am J Med Genet 1998 ;77:31-7) and/or heterozygote pathogen mutation of COL3A1 gene. * At least 4cm long normal arterial segment (carotid or femoral) analyzed by mode B echograph. * All patient received information on the research and signed the consent form. * Health system protection required General

Exclusion criteria

: * Pregnancy * Echograph gel allergy * Local Artery disease (dissection or thrombosis) * Arrhythmia * No health insurance coverage * Incapacity or refused to sign the consent form

Design outcomes

Primary

MeasureTime frameDescription
Normal Values by SSIday oneNormal Values by SSI of local PWV and arterial wall stiffness(carotid and femoral).

Secondary

MeasureTime frameDescription
repeatability of the primary outcome measureDay oneEvaluation of the repeatability of the primary outcome measure on 100 healthy volunteers and 30 patients with Vascular Ehlers Danlos Syndrome (vEDS).
Comparison between 2 populations of values by SSIDay oneComparison between healthy volunteers and vEDS patients for PWV and arterial stiffness evaluated by SSI.
Comparison of values between SSI and standard goldDay oneConcordance evaluation between PWV calculated by SSI and Aortic Pulse wave velocity calculated by ShygmoCor®

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026